Actively Recruiting

Age: 18Years +
All Genders
NCT05586867

Study of Markers of Iron Metabolism and Their Relationship With Phosphocalcic and Hepatic Metabolism and Inflammation in Hemodialysis Patients

Led by Ramsay Générale de Santé · Updated on 2022-10-19

200

Participants Needed

1

Research Sites

521 weeks

Total Duration

On this page

Sponsors

R

Ramsay Générale de Santé

Lead Sponsor

E

European Clinical Trial Experts Network

Collaborating Sponsor

AI-Summary

What this Trial Is About

From a scientific point of view and for publication purposes, it therefore seems important to study the metabolism of iron and in particular to define its conditions of absorption, metabolism, elimination and storage in the body at course of advanced renal failure. The study will follow the evolution of hormones regulating iron metabolism and put into perspective their links with phosphocalcic and hepatic metabolisms as well as inflammation in hemodialysis patients. The main objective of this program is to study the evolution of hepcidin and erythroferrone levels in hemodialysis patients. These two biomarkers regulating iron metabolism are not performed routinely in dialysis centers and are not listed in the nomenclature.

CONDITIONS

Official Title

Study of Markers of Iron Metabolism and Their Relationship With Phosphocalcic and Hepatic Metabolism and Inflammation in Hemodialysis Patients

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult dialysis patient
  • Able to understand study information and provide written consent
  • Affiliated with or beneficiary of a social security scheme
Not Eligible

You will not qualify if you...

  • Medically unstable or frail patient
  • Hemoglobin less than 7 g/dl
  • HIV positive, AIDS, or active hepatitis B or C infection
  • Participating in another clinical study requiring extra blood samples
  • Under legal protection measures (guardianship or similar)
  • Pregnant, breastfeeding, or just gave birth

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hôpital Privé Claude Galien

Quincy-sous-Sénart, France, 91480

Actively Recruiting

Loading map...

Research Team

J

Jean-François Oudet

CONTACT

M

Marie-Hélène Barba

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here